Balance of Time to Progression, Quality of Life, and Overall Survival: More Gain from Treatment in Single Agent Treatment with Mitoxantrone (N) than with the Combination of Fluorouracil, Epirubicin, Cyclophosphamide (Fec). Results of a Multicenter Randomized trial. - Heidemann,E.; Stoeger,H.; Souchon,R.; Hirschmann,W.D.; Bodenstein,H.; Oberhoff,C.; Fischer,J.; Schulze,M.; Clemens,M.; Andreesen,R.; Mahlke,M.; Konig,M .; et al. (Proc ASCO 2000 Abstr. 284)